The global Multiple Myeloma Drugs Market size was valued at USD 23.46 Billion in 2024. It is projected to reach USD 36.86 Billion by 2033, growing at a CAGR of 4.89% during 2025-2033. Growth is driven by advances in precision medicine, biomarker-driven treatments, novel drug discovery including bispecific antibodies, and improved clinical trial designs enabling faster market access. The global...